Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
14 drugs in development
By Therapeutic Area
top 6
R&D Momentum
90/100
Pipeline Velocity
69/100
Trial Completion Rate
86/100
Pipeline Concentration
18/100
Pipeline Freshness
47/100
Strategic Signals
Activity
Last 14 days
Prevalence of the Aortic to Radial Pressure Gradient in States of Shock
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis: Multicenter, Prospective, Placebo-controlled, Randomized Trial
Reliability Study of a Motor Function Measure Digitalized Playful Completion Modules
Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema
Movement Observation and Tracking In Obstetrics - Epidural and Ambulation Feasibility Study Using Inertial Sensors
Diagnostic Performance of Optical Biopsy by Cellvizio® in Gynecological Surgery
Quality of Life in Patients Having a Prosthetic Joint Infection
Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)